Similar articles

• New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment.

  Goldman JM, Lu DP. Goldman JM, et al. Semin Hematol. 1982 Oct;19(4):241-56. Semin Hematol. 1982. PMID: 6130606 Review. No abstract available.
• Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.

  Gahrton G, Lindsten J, Zech L. Gahrton G, et al. Acta Med Scand. 1974 Nov;196(5):355-60. doi: 10.1111/j.0954-6820.1974.tb01024.x. Acta Med Scand. 1974. PMID: 4531216 No abstract available.
• Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.

  Sadamori N, Sandberg AA. Sadamori N, et al. Cancer. 1984 Dec 1;54(11):2456-9. doi: 10.1002/1097-0142(19841201)54:11<2456::aid-cncr2820541124>3.0.co;2-6. Cancer. 1984. PMID: 6594187
• Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.

  Dubé ID, Kalousek DK, Coulombel L, Gupta CM, Eaves CJ, Eaves AC. Dubé ID, et al. Blood. 1984 May;63(5):1172-7. Blood. 1984. PMID: 6585234
• [Experimental and clinical use of cell cultures in chronic myeloid leukemia].

  Burgaleta C, Soria H, Moreno T. Burgaleta C, et al. Sangre (Barc). 1984;29(4-B):549-64. Sangre (Barc). 1984. PMID: 6393382 Review. Spanish. No abstract available.